Furthermore, recent studies that enhanced ARMD, by over‐expressing PGC1α in neurons as well as pharmacologically targeting PGC1α to increase mitochondrial biogenesis, showed protection of acutely demyelinated axons in EAE and lysolecithin‐induced lesions [5, 18]. The gene discussed is PPARGC1A; the disease is age-related macular degeneration.